Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients. 2017

Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands.

Keyhole limpet hemocyanin (KLH) is used as an immunogenic neo-antigen for various clinical applications and during vaccine development. For advanced monitoring of KLH-based interventions, we developed a flow cytometry-based assay for the ex vivo detection, phenotyping and isolation of KLH-specific B cells. As proof-of-principle, we analyzed 10 melanoma patients exposed to KLH during anti-cancer dendritic cell vaccination. Our assay demonstrated sensitive and specific detection of KLH-specific B cells in peripheral blood and KLH-specific B cell frequencies strongly correlated with anti-KLH serum antibody titers. Profiling of B cell subsets over the vaccination course revealed that KLH-specific B cells matured from naïve to class-switched memory B cells, confirming the prototypic B cell response to a neo-antigen. We conclude that flow-cytometric detection and in-depth phenotyping of KLH-specific B cells is specific, sensitive, and scalable. Our findings provide novel opportunities to monitor KLH-specific immune responses and serve as a blueprint for the development of new flow-cytometric protocols.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006433 Hemocyanins Metalloproteins that function as oxygen transport proteins in the HEMOLYMPH of MOLLUSKS and ARTHROPODS. They are characterized by two copper atoms, coordinated with HISTIDINE residues, that reversibly bind a single oxygen molecule; they do not contain HEME groups. Hemocyanin,alpha-Haemocyanin,alpha-Hemocyanin,alpha-Hemocyanins,alpha Haemocyanin,alpha Hemocyanin,alpha Hemocyanins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
October 2001, Journal of cancer research and clinical oncology,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
December 1999, Micron (Oxford, England : 1993),
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
March 1993, The Journal of urology,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
January 1991, Die Naturwissenschaften,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
September 1995, Cancer immunology, immunotherapy : CII,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
January 1996, Anticancer research,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
October 2001, Journal of cancer research and clinical oncology,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
February 1997, Micron (Oxford, England : 1993),
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
June 1994, Journal of biochemistry,
Florian Wimmers, and Nienke de Haas, and Anja Scholzen, and Gerty Schreibelt, and Elles Simonetti, and Marc J Eleveld, and Huberdina M L M Brouwers, and Marjo Beldhuis-Valkis, and Irma Joosten, and Marien I de Jonge, and Winald R Gerritsen, and I Jolanda M de Vries, and Dimitri A Diavatopoulos, and Joannes F M Jacobs
June 2018, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!